Showing results (41-50 of 190) with videos related to

Sort By:
Pageof 19
International Journal of Cancer|April 5, 2008
EGFR tyrosine kinase inhibition radiosensitizes and induces apoptosis in malignant glioma and childhood ependymoma xenograftsBirgit Geoerger, Nathalie Gaspar, Paule Opolon, et al.
Pediatric Blood & Cancer|December 31, 2013
Vemurafenib in pediatric patients with BRAFV600E mutated high-grade gliomasFrancisco Bautista, Angelo Paci, Veronique Minard-Colin, et al.
Cancer Genetics|April 29, 2017
Genomic diagnostics leading to the identification of a TFG-ROS1 fusion in a child with possible atypical meningiomaMaria Rossing, Christina Westmose Yde, Astrid Sehested, et al.
Nature|December 2, 2021
Local circuit amplification of spatial selectivity in the hippocampusTristan Geiller, Sadra Sadeh, Sebastian V Rolotti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 5, 2008
Population pharmacokinetics and pharmacogenetics of imatinib in children and adultsAurélie Petain, Darouna Kattygnarath, Julie Azard, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 5, 2018
Discovery of New Fusion Transcripts in a Cohort of Pediatric Solid Cancers at Relapse and Relevance for Personalized MedicineCélia Dupain, Anne C Harttrampf, Yannick Boursin, et al.
Cancer Treatment Reviews|March 17, 2010
The role of the 'innovative therapies for children with cancer' (ITCC) European consortiumC Michel Zwaan, Pamela Kearns, Huib Caron, et al.
ACS Chemical Biology|July 10, 2010
Targeting multifunctional proteins by virtual screening: structurally diverse cytohesin inhibitors with differentiated biological functionsDagmar Stumpfe, Anke Bill, Nina Novak, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 10, 2011
Population analysis of erlotinib in adults and children reveals pharmacokinetic characteristics as the main factor explaining tolerance particularities in childrenMelanie White-Koning, Elodie Civade, Birgit Geoerger, et al.
Neuro-Oncology Practice|December 29, 2025
Dabrafenib in pediatric patients with BRAF V600 mutation-positive high-grade glioma: Results from a phase 1/2a single-arm studyBirgit Geoerger, Lucas Moreno, Eric Bouffet, et al.
Pageof 19